IND Clearance to First Patient In: The Sponsor Critical Path

Map the path from an effective IND to an executable first-patient event. Use parallel regulatory, site, systems and supply gates, with accepted evidence and owner decisions.
Managing Multiple Clinical Trial Vendors Without Losing Sponsor Control

Practical sponsor governance for studies using several CRO, laboratory, system and supply providers. Includes a reusable cross-vendor handoff register with owners, acceptance evidence and escalation decisions.
Replace the CRO or Remediate the Relationship? A Sponsor Decision Framework

Replace the CRO or Remediate the Relationship? A Sponsor Decision Framework helps clinical development sponsors turn an unstable operating situation into a controlled sequence of evidence, accountability, and explicit decisions. The purpose is to assess what is known, identify what remains uncertain, and choose actions that protect participants and data while making the project executable.
Clinical Trial Enrollment Delay: Sponsor Recovery Plan

A clinical trial enrollment delay needs a sponsor-owned recovery plan grounded in the site funnel, eligibility criteria, activation readiness, screened-to-enrolled conversion and local operational constraints. Recruitment activity alone does not prove that enrollment forecasts are achievable.
Underperforming CRO or Vendor? Sponsor Diagnostic Framework

An underperforming CRO should be assessed using objective evidence before the sponsor decides to remediate, augment, or replace the provider. The diagnostic separates a late deliverable from a capability gap, unclear scope, insufficient sponsor decisions, and a material quality or safety failure.
Clinical Trial Timeline Recovery: What to Do When Milestones Slip

Clinical trial timeline recovery begins by verifying the actual failed dependency, protecting participant safety and data integrity, and building a new evidence-based critical path. Simply moving the final milestone date does not resolve the cause of delay.
Phase I Clinical Trial Timeline: From Final Protocol to First Patient In and Beyond

A phase 1 clinical trial timeline should connect the sponsor’s final protocol to the regulatory, site, vendor, systems and supply evidence needed before the first participant receives an investigational product. First-pa
How to Build a Clinical Trial Responsibility Matrix Before Vendor Kickoff

Clinical trial responsibility matrix development should begin before sponsor, CRO, laboratory, data-management and technology teams start exchanging deliverables. A useful matrix identifies the person who performs each a
ICH E3 Clinical Study Report Structure: A Sponsor-Friendly Guide

ICH E3 clinical study report structure gives sponsors a common way to explain what a trial set out to test, what happened, how the data were analyzed, what was observed, and how the sponsor interprets the results. It is
CSR Timeline Planning: From Database Lock to Final Sponsor Approval

Clinical study report timeline should be planned as a set of dependent decisions, not a fixed number of days after database lock. The critical path runs through controlled data, approved statistical outputs, clinical and